email invite

NINDS Clinical Trial Networks Discussion Groups: Text for email messages

Dear NeuroNEXT / NIH StrokeNet participant,

Thank you for your responses to the NINDS feedback survey of NeuroNEXT/ NIH StrokeNet. We are writing you now because you indicated in the survey that you might be willing to participate in a follow up discussion to further elaborate on your experiences with the network.

We would like to invite you to participate in a 60-minute discussion with a small group of your network colleagues so that we can better understand your survey responses and use them inform future network improvements.

Discussion group sessions will be held via Zoom and moderated by outside experts with relevant backgrounds in academic research, industry, and patient communities. If you are interested in participating in a discussion group session, please reply to this email and indicate which of the below scheduled sessions you are available to attend:

1-2pm EST September 20, 2021

1-2pm EST September 21, 2021

1-2pm EST September 22, 2021

1-2pm EST September 23, 2021

1-2pm EST September 24, 2021

1-2pm EST September 27, 2021

Based on your availability, we may send you an invitation to participate in one of these sessions.

Your participation in a discussion group session is voluntary. Please note that we plan to record these sessions for notetaking purposes only. Your responses will not be identified with you personally or with your organization; survey and discussion group results will be reported only in aggregate or de-identified form.

Thank you in advance for sharing your thoughts and experiences with us. If you have any questions regarding your participation in the survey or a discussion group session, please contact Dr. Cristina Nigro (cristina.nigro@nih.gov).

1